COMMUNIQUÉS West-GlobeNewswire

Microbix Provides Quality Assessment Products Update
05/02/2019
New Customers, More Products, and Expanding Capacity TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, Microbix®), an innovator of biological products and technologies, provides an update on [...]
BioCryst to Present ZENITH-1 Results at American Academy of Allergy, Asthma & Immunology Annual Meeting
05/02/2019
RESEARCH TRIANGLE PARK, N.C., Feb. 05, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present an abstract including results from the ZENITH-1 study at the [...]
Harrow Health Announces $11 Million Series A Financing for Melt Pharmaceuticals Subsidiary
05/02/2019
Investment will enable Melt to fund the development of its patented, non-opioid sublingual sedation and analgesia drug candidate, MELT-100 SAN DIEGO and BOSTON, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Melt Pharmaceuticals, [...]
Protalix BioTherapeutics Presents Preliminary Data from the BRIGHT Study of pegunigalsidase alfa for the Treatment of Fabry Disease at the 15th Annual WORLDSymposium™ 2019
05/02/2019
~ Pharmacokinetic data from patients treated in the study show that infusion of pegunigalsidase alfa every 4 weeks results in the presence of continuous active enzyme throughout the entire infusion interval~ ~Continuous [...]
Revive Announces Closing of the First Tranche of Its Non-Brokered Private Placement for Total Gross Proceeds of Over $1 Million
05/02/2019
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Revive Therapeutics [...]
Tetra Bio-Pharma Redefines Quality Standards for Pharmaceutical Grade Cannabis-Derived Products
05/02/2019
Patient safety is primary imperative ORLEANS, Ontario, Feb. 05, 2019 (GLOBE NEWSWIRE) -- Tetra Bio-Pharma Inc. (" Tetra " or the " Company ") (TSX-V: TBP) (OTCQB: TBPMF), today announced that it has temporarily [...]
CorVel Announces Revenues and Earnings
05/02/2019
IRVINE, Calif., Feb. 05, 2019 (GLOBE NEWSWIRE) -- CorVel Corporation (NASDAQ: CRVL) announced the results for the quarter ended December 31, 2018. Revenues for the quarter ended December 31, 2018 were $146 million, an [...]
Coloplast delivers solid start to the year with 8% organic growth
05/02/2019
Coloplast delivered 8% organic growth and EBIT increased by 8% to DKK 1,297m, corresponding to an EBIT margin of 30%, in the first quarter of the 2018/19 financial year. The company maintains its financial guidance for [...]
Press release: Terveystalo dental clinic network expands - Länsi-Vantaan Hammaslääkärit Oy to become a part of Terveystalo
05/02/2019
Terveystalo has signed an agreement to acquire Länsi-Vantaan Hammaslääkärit Oy, a private clinic that offers oral health services in Vantaa. The company's employees will be transferred to Terveystalo as old employees [...]
Announcement no. 1/2019 – Interim Financial Report, Q1 2018/19
05/02/2019
Q1 2018/19 Interim financial report, Q1 2018/19 (01 October 2018 - 31 December 2018) Solid start to the year, guidance for 2018/19 maintained Coloplast delivered 8% organic growth in the first quarter. Reported revenue [...]
Nu-Med Plus, Inc. Produces New, Smaller, and Smarter Inhaled Nitric Oxide Delivery Unit for Clinical Settings
05/02/2019
Nu-Med Plus’s inhaled nitric oxide clinical unit is designed to open new patient markets by providing in-office treatment options for conditions such as high blood pressure, COPD and ARDS SALT LAKE CITY, Feb. 05, 2019 ( [...]
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL) - UPDATED VERSION
05/02/2019
THE SHAREHOLDERS OF OASMIA PHARMACEUTICAL AB (PUBL) ARE HEREBY GIVEN NOTICE OF THE EXTRAORDINARY GENERAL MEETING ON TUESDAY 19 MARCH 2019, AT 14.00 P.M., AT THE OFFICES OF THE COMPANY AT VALLONGATAN 1, 752 28 UPPSALA. [...]
NOTICE OF EXTRAORDINARY GENERAL MEETING IN OASMIA PHARMACEUTICAL AB (PUBL)
05/02/2019
THE SHAREHOLDERS OF OASMIA PHARMACEUTICAL AB (PUBL) ARE HEREBY GIVEN NOTICE OF THE EXTRAORDINARY GENERAL MEETING ON TUESDAY 19 MARCH 2019, AT 14.00 P.M., AT THE OFFICES OF THE COMPANY AT VALLONGATAN 1, 752 28 UPPSALA. [...]
Transactions in relation to share buyback program
05/02/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 2, 2018, in accordance with article 5 of the regulation (EU) no. 596/2014 of 16 April 2014 on [...]
LIDDS adds another Scandinavian clinic to the NZ-DTX-001 clinical trial
05/02/2019
UPPSALA, SWEDEN - LIDDS AB (publ) has received approval from the Danish Medicines Agency (DKMA) to conduct its Phase I NZ-DTX-001 clinical trial. The Danish study is in addition to the Phase I NZ-DTX-001 clinical trial [...]
Novo Nordisk files annual report with the SEC
05/02/2019
Bagsværd, Denmark, 5 February 2019 - Novo Nordisk A/S has filed its Annual Report 2018 on Form 20-F for the financial year 2018 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of [...]
CellaVision AB launches new product, CellaVision® DC-1, for small and mid-sized hematology laboratories
05/02/2019
The information was released for public disclosure on February 5, 2019, at 08:20. The CellaVision® DC-1 strengthens the company's global position and opens a new segment of the market comprising about 100,000 small and [...]
Ossur Hf : Annual Report 2018
05/02/2019
Announcement no. 8/2019 Annual Report 2018 5 February 2019 Össur's Annual Report 2018 has just been published and is available for download at the link below. Online version of the Annual Report 2018 is available at [...]
Ossur Hf : Interim report Q4 2018
05/02/2019
Announcement no. 7/2019 Interim report Q4 2018 5 February 2019 Highlights Sales growth of 12% in local currency in Q4 2018, organic sales growth of 4% and reported growth of 9%. Sales growth of 7% in local currency in [...]

Pages